IMMUNO-THERATRACE

Serial Number 97713776
Registration 7573277
700

Registration Progress

Application Filed
Dec 12, 2022
Under Examination
Jan 16, 2024
Approved for Publication
Nov 21, 2023
Published for Opposition
Nov 21, 2023
Registered
Nov 19, 2024

Trademark Image

IMMUNO-THERATRACE

Basic Information

Serial Number
97713776
Registration Number
7573277
Filing Date
December 12, 2022
Registration Date
November 19, 2024
Published for Opposition
November 21, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 19, 2024
Registration
Registered
Classes
042

Rights Holder

Melior Discovery, Inc.

03
Address
860 Springdale Drive, Suite 500
Exton, PA 19341

Ownership History

Melior Discovery, Inc.

Original Applicant
03
Exton, PA

Melior Discovery, Inc.

Owner at Publication
03
Exton, PA

Melior Discovery, Inc.

Original Registrant
03
Exton, PA

Legal Representation

Attorney
Leslie H Smith

USPTO Deadlines

Next Deadline
1935 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-11-19)
Due Date
November 19, 2030
Grace Period Ends
May 19, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

31 events
Date Code Type Description Documents
Nov 19, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 19, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 16, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 16, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 11, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 10, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 9, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 9, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 9, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 9, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 9, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 9, 2024 IUAF S USE AMENDMENT FILED Loading...
Jan 16, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 21, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 21, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 1, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 12, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 10, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 10, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 10, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Oct 10, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 10, 2023 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Oct 6, 2023 PBMR Z WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST Loading...
Oct 5, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 5, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 5, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 5, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 5, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 15, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 9, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 15, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
scientific research; pharmaceutical research services; testing of pharmaceuticals; contract research services, namely, pharmaceutical contract research services
First Use Anywhere: Feb 28, 2023
First Use in Commerce: Feb 28, 2023

Classification

International Classes
042